converting from semaglutide to tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are semaglutide to tirzepatide conversion chart

GLP-1 medications reduce appetite in ways that change how and how much most people eat

Fridays New moms dont have a ton of time on their hands, which is why Fridays is the best match for those who need a weight-loss program streamlined in one place

Notably, nausea and vomiting were predominantly mild, transie

The injectable version is taken once per week and is FDA-approved for adults with type 2 diabetes to: Improve blood sugar when combined with diet and exercise Reduce the risk of heart attack, stroke, or cardiovascular death in adults who also have known heart disease Reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults who also have chronic kidney disease

February 26, 2025 New NAION Study A recent study published last week in JAMA Ophthalmology investigated the potential link between semaglutide and non-arteritic anterior ischemic optic neuropathy (NAION), a rare eye condition that can lead to sudden vision loss

The process has the characteristics of high safety, low cost and high purity